The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group
- PMID: 10027502
The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group
Abstract
The Childhood Asthma Management Program (CAMP) is a multicenter, randomized, double-masked clinical trial designed to determine the long-term effects of three inhaled treatments for mild to moderate childhood asthma: budesonide (a glucocorticoid used daily) and albuterol (a short-acting beta-agonist bronchodilator used as needed); nedocromil (a nonsteroid anti-inflammatory agent used daily) and albuterol; and placebo and albuterol. One thousand forty-one children (32% from ethnic minority groups), aged 5 to 12 years at screening, are currently participating. The primary outcome measure is lung growth as indicated by postbronchodilator forced expiratory volume in 1 second (FEV1) percent of predicted, observed over 5- to 6-year period. The trial also assesses differences between treatment groups with respect to airway responsiveness, morbidity, physical growth and development, and psychological growth and development. This report describes the design of the trial, the rationale for the design choices made, and the methods used to carry out the trial.
Similar articles
-
Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma.Pediatrics. 2006 Aug;118(2):e347-55. doi: 10.1542/peds.2005-2962. Epub 2006 Jul 24. Pediatrics. 2006. PMID: 16864642
-
Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma.J Pediatr. 2003 May;142(5):469-75. doi: 10.1067/mpd.2003.187. J Pediatr. 2003. PMID: 12756375 Clinical Trial.
-
Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.Clin Ther. 2008 Aug;30(8):1492-504. doi: 10.1016/j.clinthera.2008.07.018. Clin Ther. 2008. PMID: 18803991 Clinical Trial.
-
[Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].Med Klin (Munich). 2008 May 15;103(5):299-310. doi: 10.1007/s00063-008-1050-y. Med Klin (Munich). 2008. PMID: 18484216 Review. German.
-
The need for precision medicine clinical trials in childhood asthma: rationale and design of the PUFFIN trial.Pharmacogenomics. 2017 Mar;18(4):393-401. doi: 10.2217/pgs-2016-0174. Epub 2017 Feb 22. Pharmacogenomics. 2017. PMID: 28244806 Review.
Cited by
-
Dimensions of Socioeconomic Status and Childhood Asthma Outcomes: Evidence for Distinct Behavioral and Biological Associations.Psychosom Med. 2016 Nov-Dec;78(9):1043-1052. doi: 10.1097/PSY.0000000000000392. Psychosom Med. 2016. PMID: 27749682 Free PMC article.
-
Copy number variation genotyping using family information.BMC Bioinformatics. 2013 May 9;14:157. doi: 10.1186/1471-2105-14-157. BMC Bioinformatics. 2013. PMID: 23656838 Free PMC article.
-
Pharmacogenetic Polygenic Risk Score for Bronchodilator Response in Children and Adolescents with Asthma: Proof-of-Concept.J Pers Med. 2021 Apr 20;11(4):319. doi: 10.3390/jpm11040319. J Pers Med. 2021. PMID: 33923870 Free PMC article.
-
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma.N Engl J Med. 2016 May 12;374(19):1842-1852. doi: 10.1056/NEJMoa1513737. N Engl J Med. 2016. PMID: 27168434 Free PMC article. Clinical Trial.
-
IL10 gene polymorphisms are associated with asthma phenotypes in children.Genet Epidemiol. 2004 Feb;26(2):155-65. doi: 10.1002/gepi.10298. Genet Epidemiol. 2004. PMID: 14748015 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
